DUBLIN--(BUSINESS WIRE)--The "Respiratory Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024" report has been added to ResearchAndMarkets.com's offering.
The global respiratory diagnostics market reached a value of US$ 4.4 Billion in 2018. Looking forward, the market is projected to reach a value of US$ 6.5 Billion by 2024, registering a CAGR of 6.6% during 2019-2024.
The growing prevalence of respiratory diseases is one of the key factors driving the growth of the market. The increasing number of smokers and consumption of alcohol, coupled with sedentary lifestyle habits and stressful routines, have resulted in rising incidences of COPD and other severe respiratory conditions, such as lung cancer.
Furthermore, various technological innovations in respiratory diagnostic testing, including the utilization of Internet of Things (IoT) and Artificial Intelligence (AI) for the diagnosis of COPD and outpatient management, are creating a positive impact on the market growth.
Also, an increase in the demand for respiratory diagnostics devices in various privately-owned hospitals and healthcare centers and efforts by both government and non-governmental organizations (NGO) to make quality healthcare facilities accessible to all are driving the market for respiratory diagnostics.
Other factors contributing to the market growth include enhanced research and development (R&D), rising geriatric population, rapid urbanization and increasing industrial establishments, and growing pollution levels across the globe.
The report has also analyzed the competitive landscape of the market with some of the key players being Philips Healthcare, Abbott Laboratories, Biomerieux, Becton Dickinson, Thermo Fisher Scientific, Alere Inc., Seegene Inc., 3M, Bio-Rad Laboratories, SDI Diagnostics, COSMED, etc.
Key Questions Answered in This Report
- How has the global respiratory diagnostics market performed so far and how will it perform in the coming years?
- What are the key regional markets in the global respiratory diagnostics industry?
- What is the breakup of the market based on the products and service type?
- What is the breakup of the market based on the test type?
- What is the breakup of the market based on the disease?
- What is the breakup of the market based on the end-user?
- What are the various stages in the value chain of the global respiratory diagnostics industry?
- What are the key driving factors and challenges in the global respiratory diagnostics industry?
- What is the structure of the global respiratory diagnostics industry and who are the key players?
- What is the degree of competition in the global respiratory diagnostics industry?
Key Topics Covered
2 Scope and Methodology
3 Executive Summary
4.2 Key Industry Trends
5 Global Respiratory Diagnostics Market
5.1 Market Overview
5.2 Market Performance
5.3 Market Breakup by Product and Service Type
5.4 Market Breakup by Test Type
5.5 Market Breakup by Disease
5.6 Market Breakup by End-user
5.7 Market Breakup by Region
5.8 Market Forecast
6 Market Breakup by Product and Service Type
6.1 Instruments and Services
6.2 Assays and Reagents
6.3 Services and Software
7 Market Breakup by Test Type
7.1 Mechanical Tests
7.2 Obstructive Sleep Apnoea (OSA) Diagnostic Tests
7.3 Imaging Tests
7.4 Traditional Diagnostic Tests
7.5 Molecular Diagnostic Tests
8 Market Breakup by Disease
8.3 Chronic Obstructive Pulmonary Disease (COPD)
8.4 Lung Cancer
9 Market Breakup by End User
9.3 Reference and Clinical Laboratories
10 Market Breakup by Region
10.1 North America
10.3 Asia Pacific
10.4 Middle East and Africa
10.5 Latin America
11 SWOT Analysis
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Philips Healthcare
14.3.2 Abbott Laboratories
14.3.4 Becton Dickinson
14.3.5 Thermo Fisher Scientific Inc.
14.3.6 Alere Inc.
14.3.7 Seegene Inc.
14.3.9 Bio-Rad Laboratories Inc.
14.3.10 SDI Diagnostics
For more information about this report visit https://www.researchandmarkets.com/r/wymfpr